S 1954 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill appears to deal with reducing rules or requirements related to biosimilars, which are medicines made to work very similarly to existing brand-name biological drugs. No official summary is available for this bill.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.